208 related articles for article (PubMed ID: 26854349)
21. Chemotherapy of Aujeszky's disease (pseudorabies) in the mouse by means of nucleoside analogues: bromovinyldeoxyuridine, acyclovir, and dihydroxypropoxymethylguanine.
Field HJ
Antiviral Res; 1985 Jun; 5(3):157-68. PubMed ID: 2992370
[TBL] [Abstract][Full Text] [Related]
22. Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus.
Zhou M; Abid M; Cao S; Zhu S
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016377
[TBL] [Abstract][Full Text] [Related]
23. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
24. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
25. Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines.
Zídek Z; Potmesil P; Kmoníèková E; Holý A
Eur J Pharmacol; 2003 Aug; 475(1-3):149-59. PubMed ID: 12954371
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
Mettenleiter TC; Klupp BG; Weiland F; Visser N
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
[TBL] [Abstract][Full Text] [Related]
27. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Andrei G; Topalis D; De Schutter T; Snoeck R
Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
[TBL] [Abstract][Full Text] [Related]
28. Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
Kmonícková E; Potmesil P; Holý A; Zídek Z
Eur J Pharmacol; 2006 Jan; 530(1-2):179-87. PubMed ID: 16371225
[TBL] [Abstract][Full Text] [Related]
29. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
[TBL] [Abstract][Full Text] [Related]
30. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
31. [Progress in the development of vaccines against Aujeszky's disease].
Mettenleiter TC
Tierarztl Prax; 1995 Dec; 23(6):570-4. PubMed ID: 8585074
[TBL] [Abstract][Full Text] [Related]
32. The effect of Houttuynia cordata injection on pseudorabies herpesvirus (PrV) infection in vitro.
Ren X; Sui X; Yin J
Pharm Biol; 2011 Feb; 49(2):161-6. PubMed ID: 20942608
[TBL] [Abstract][Full Text] [Related]
33. Venereal transmission of pseudorabies viruses indigenous to feral swine.
Romero CH; Meade PN; Shultz JE; Chung HY; Gibbs EP; Hahn EC; Lollis G
J Wildl Dis; 2001 Apr; 37(2):289-96. PubMed ID: 11310879
[TBL] [Abstract][Full Text] [Related]
34. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
Balzarini J; Holy A; Jindrich J; Naesens L; Snoeck R; Schols D; De Clercq E
Antimicrob Agents Chemother; 1993 Feb; 37(2):332-8. PubMed ID: 8452366
[TBL] [Abstract][Full Text] [Related]
35. Phosphonomethoxyalkyl analogs of nucleotides.
Holy A
Curr Pharm Des; 2003; 9(31):2567-92. PubMed ID: 14529543
[TBL] [Abstract][Full Text] [Related]
36. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
[TBL] [Abstract][Full Text] [Related]
37. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
38. Antiviral effectiveness of butylated hydroxytoluene against pseudorabies (Aujeszky's disease) virus in cell culture, mice, and swine.
Pirtle EC; Sacks JM; Nachman RJ
Am J Vet Res; 1986 Sep; 47(9):1892-5. PubMed ID: 3021025
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of dUTPase-deficient pseudorabies virus for the natural host.
Jöns A; Gerdts V; Lange E; Kaden V; Mettenleiter TC
Vet Microbiol; 1997 May; 56(1-2):47-54. PubMed ID: 9228681
[TBL] [Abstract][Full Text] [Related]
40. Porcine IFITM1 is a host restriction factor that inhibits pseudorabies virus infection.
Wang J; Wang CF; Ming SL; Li GL; Zeng L; Wang MD; Su BQ; Wang Q; Yang GY; Chu BB
Int J Biol Macromol; 2020 May; 151():1181-1193. PubMed ID: 31743714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
